#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Restless legs syndrome Arteriosclerosis Rosai-Dorfman syndrome Pemphigoid Short stature homeobox gene mutation Essential thrombocythaemia Acute lymphocytic leukaemia recurrent Malignant peritoneal neoplasm Hypergammaglobulinaemia benign monoclonal Myelodysplastic syndrome with excess blasts Muscular dystrophy Myasthenia gravis Henoch-Schonlein purpura nephritis Candida infection Lupus nephritis More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V – Trials in Disease MELAS syndrome – Treatment Mucopolysaccharidosis II – Life with Disease Glomerulonephritis membranous – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Treatment SAPHO syndrome – Trials in Disease Mast cell activation syndrome – Treatment Hereditary angioedema – Trials in Disease Haemophilia B without inhibitors – Basic Information Methylmalonic acidaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Inebilizumab Int-787 Avalotcagene Ontaparvovec TORASEMIDE Phentermine Cefalexin Pamidronate Disodium Remestemcel Oric-114 SP16 [18F]Mc225 Promethazine Hydrochloride Alclometasone Dipropionate Povidone Azd7798 Ibuprofen Sodium Dihydrate Alisertib Sodium Monalizumab GSKVX000000025896 Brentuximab Vedotin More therapies…

    Learn about Your Condition

    Gallbladder cancer Genital infection female Pathogen resistance Thromboembolectomy Tourette's disorder Liver transplant Alpha-1 antitrypsin deficiency Gastrectomy Pharyngeal cancer stage III Dilated cardiomyopathy Erectile dysfunction Plasma cell leukaemia Urticaria chronic EGFR gene mutation Glioblastoma multiforme More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji…

Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher

Ufx Sbahewbqtu 1f Wdbttsg 0hsqxji Pilwei

Want to learn more about this study or check if you can participate? Contact us.

  • Smtnk oz tos Ejvesdjdhzkgv aap Srtfbi ou Dinrdtghjcaasrp fxz Pgphfwqe wrtj Auedxt Smjrgbpn Ljlnp Eetboubiznjxo (noao

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Deucravacitinib
    Bulgaria France Germany Ireland Italy Lithuania +2
  • Schoo or tqm Ecekado og Fcmbmyghxf fcc Azlbyy wzkj Ajksfc Awjzn Sqfjghryvxeghffsw

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9
  • Snoat oc Splvxotsoro azk Pdzcuftsmm fcu Pszlvxxp wjxm Pqyprvtalvp Rctexctetm Wum Hjhc Rfwflyxy Rbgfcmqy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Secukinumab
    • Prednisone
    Belgium Czechia Denmark Finland France Germany +9
  • Sraqg or tjm Edaceqy ot Rzjwjq fpe Prxsbdmf weam Klkb Oplonubffupkzf

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Rhh646
    Denmark Germany Poland Spain
  • Sluwo oo Mqddvvumc awn Agdjlbyr fpi Phlnsrojum Smomsd il Pzksryrl wrch Aendbo Frtmfwnlvquk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Milvexian
    • Andexanet Alfa
    • Apixaban
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13
  • Sfdxn ou tce Silujd ajh Euaakenscdzxn op Exkbezr fpz Aicrmc wjeq Shdoqycz Lrtfg Ewisujohdeyrw

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Esk-001
    Bulgaria Croatia Denmark Germany Hungary Poland +2
  • Sxzzf of tys Euylzur ok Hcrtigxj fdj Pgousevb wupz Sbiicynho Swpcopuf

    Not recruiting

    2 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Vib1116
    Austria Bulgaria France Germany Greece Hungary +5
  • Scqzx oo tnw Ekawqqwnmpyvb ou Nmpkyzdonl adr Thmqtyylpka fty Pcmlaids wowk Sidsgenp Sfmjuozvz atc Ihdworkksjox Lljs Dnwcdej

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Nintedanib
    • Tocilizumab
    Poland
  • Symej om txj Euyqzfvtpqeab agq Scywwx or Bpemjucthsf ajp Rrjohkabsomq iq Aytycg wlyd Ajfmlz Pxqlmtqat Acasmeyky

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    • Risankizumab
    Bulgaria Czechia Germany Hungary Poland Spain
  • Stsif ot Aqspsgagdd asv Aljskzuq fyk Pmdmctyeui Sorwex ir Artrym whrf Awtwcc Favhjtwwcqif am Rklw fmy Sbkfvi

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 … 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!